Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteogenic Differentiation Potential of Mesenchymal Stem Cells Using Single Cell Multiomic Analysis. | Genes (Basel) | 2023 | 37895219 | PubTator, text mining | PubMed |
| A Small De Novo CNV Deletion of the Paternal Copy of FOXF1, Leaving lncRNA FENDRR Intact, Provides Insight into Their Bidirectional Promoter Region. | Noncoding RNA | 2023 | 37888207 | PubTator, text mining | PubMed |
| Aurora Kinase A Regulates Cell Transitions in Glucocorticoid-Induced Bone Loss. | Cells | 2023 | 37887278 | PubTator, text mining | PubMed |
| Modeling of intramembranous ossification using human pluripotent stem cell-derived paraxial mesoderm derivatives. | Regen Ther | 2023 | 37860130 | PubTator, text mining | PubMed |
| MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis. | Front Oncol | 2023 | 37854681 | PubTator, text mining | PubMed |
| New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons. | Front Cell Dev Biol | 2023 | 37849741 | PubTator, text mining | PubMed |
| The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens. | Technol Cancer Res Treat | 2023 | 37849311 | PubTator, text mining | PubMed |
| Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function. | Front Cell Dev Biol | 2023 | 37842094 | PubTator, text mining | PubMed |
| The Glioblastoma CircularRNAome. | Int J Mol Sci | 2023 | 37833993 | PubTator, text mining | PubMed |
| Case report: Noonan syndrome with protein-losing enteropathy. | Front Genet | 2023 | 37829277 | PubTator, text mining | PubMed |
| Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer. | Cell Mol Life Sci | 2023 | 37815603 | PubTator, text mining | PubMed |
| Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer. | Cancer Res Commun | 2023 | 37812088 | PubTator, text mining | PubMed |
| Congenital pulmonary lymphatic duct hypoplasia in a fetus with hydrops fetalis found at delivery: A case report. | Heliyon | 2023 | 37810008 | PubTator, text mining | PubMed |
| Lymphangiogenesis in gastric cancer: function and mechanism. | Eur J Med Res | 2023 | 37803421 | PubTator, text mining | PubMed |
| The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition. | Breast Cancer Res | 2023 | 37794509 | PubTator, text mining | PubMed |
| Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer. | Front Pharmacol | 2023 | 37781691 | PubTator, text mining | PubMed |
| ANP32A Knockdown Attenuates the Malignant Biological Behavior of Colorectal Cancer Cells by Suppressing Epithelial-mesenchymal Transition and ERK Activation. | J Cancer | 2023 | 37781083 | PubTator, text mining | PubMed |
| A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer. | J Cancer | 2023 | 37779874 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. | NPJ Regen Med | 2023 | 37773257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers?page=8